1. Home
  2. HTBK vs DAWN Comparison

HTBK vs DAWN Comparison

Compare HTBK & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • DAWN
  • Stock Information
  • Founded
  • HTBK 1997
  • DAWN 2018
  • Country
  • HTBK United States
  • DAWN United States
  • Employees
  • HTBK N/A
  • DAWN N/A
  • Industry
  • HTBK Major Banks
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • DAWN Health Care
  • Exchange
  • HTBK Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • HTBK 588.2M
  • DAWN 658.9M
  • IPO Year
  • HTBK 1998
  • DAWN 2021
  • Fundamental
  • Price
  • HTBK $9.30
  • DAWN $6.10
  • Analyst Decision
  • HTBK Buy
  • DAWN Strong Buy
  • Analyst Count
  • HTBK 3
  • DAWN 7
  • Target Price
  • HTBK $11.33
  • DAWN $27.86
  • AVG Volume (30 Days)
  • HTBK 660.9K
  • DAWN 2.0M
  • Earning Date
  • HTBK 07-24-2025
  • DAWN 08-05-2025
  • Dividend Yield
  • HTBK 5.58%
  • DAWN N/A
  • EPS Growth
  • HTBK N/A
  • DAWN N/A
  • EPS
  • HTBK 0.63
  • DAWN N/A
  • Revenue
  • HTBK $180,089,000.00
  • DAWN $187,638,000.00
  • Revenue This Year
  • HTBK $10.40
  • DAWN $16.42
  • Revenue Next Year
  • HTBK $7.12
  • DAWN $47.52
  • P/E Ratio
  • HTBK $14.79
  • DAWN N/A
  • Revenue Growth
  • HTBK 3.15
  • DAWN 2190.50
  • 52 Week Low
  • HTBK $8.09
  • DAWN $5.64
  • 52 Week High
  • HTBK $11.27
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 37.39
  • DAWN 39.80
  • Support Level
  • HTBK $9.27
  • DAWN $5.64
  • Resistance Level
  • HTBK $9.56
  • DAWN $7.04
  • Average True Range (ATR)
  • HTBK 0.24
  • DAWN 0.32
  • MACD
  • HTBK -0.07
  • DAWN -0.10
  • Stochastic Oscillator
  • HTBK 21.05
  • DAWN 26.35

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: